
Friedrich Fahnert
Examiner (ID: 7481, Phone: (571)270-7797 , Office: P/2654 )
| Most Active Art Unit | 2654 |
| Art Unit(s) | 2614, 2692, 2654, 2651 |
| Total Applications | 770 |
| Issued Applications | 644 |
| Pending Applications | 40 |
| Abandoned Applications | 106 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10459830
[patent_doc_number] => 20150344838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'REDUCED GENOME E. COLI'
[patent_app_type] => utility
[patent_app_number] => 14/803923
[patent_app_country] => US
[patent_app_date] => 2015-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 41752
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14803923
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/803923 | REDUCED GENOME E. COLI | Jul 19, 2015 | Abandoned |
Array
(
[id] => 11851669
[patent_doc_number] => 20170226161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/319651
[patent_app_country] => US
[patent_app_date] => 2015-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22205
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319651
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/319651 | Modified meningococcal fHbp polypeptides | Jul 15, 2015 | Issued |
Array
(
[id] => 15571501
[patent_doc_number] => 10576109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 15/326265
[patent_app_country] => US
[patent_app_date] => 2015-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4369
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326265
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326265 | None | Jul 15, 2015 | Issued |
Array
(
[id] => 13106843
[patent_doc_number] => 10072054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-11
[patent_title] => Vaccine and methods for detecting and preventing filariasis
[patent_app_type] => utility
[patent_app_number] => 14/798945
[patent_app_country] => US
[patent_app_date] => 2015-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 28491
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14798945
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/798945 | Vaccine and methods for detecting and preventing filariasis | Jul 13, 2015 | Issued |
Array
(
[id] => 11689631
[patent_doc_number] => 20170165347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'HELICOBACTER THERAPEUTIC'
[patent_app_type] => utility
[patent_app_number] => 15/321933
[patent_app_country] => US
[patent_app_date] => 2015-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12246
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321933
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/321933 | HELICOBACTER THERAPEUTIC | Jun 29, 2015 | Abandoned |
Array
(
[id] => 11836312
[patent_doc_number] => 20170218031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'CLOSTRIDIUM DIFFICILE IMMUNOGENIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/320190
[patent_app_country] => US
[patent_app_date] => 2015-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 30598
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320190
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320190 | CLOSTRIDIUM DIFFICILE IMMUNOGENIC COMPOSITION | Jun 24, 2015 | Abandoned |
Array
(
[id] => 15512741
[patent_doc_number] => 10562946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Chagasin-based scaffold compositions, methods, and uses
[patent_app_type] => utility
[patent_app_number] => 15/320736
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 15
[patent_no_of_words] => 47966
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320736
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320736 | Chagasin-based scaffold compositions, methods, and uses | Jun 18, 2015 | Issued |
Array
(
[id] => 17207773
[patent_doc_number] => 11168132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-09
[patent_title] => Treatment of polybacterial infections
[patent_app_type] => utility
[patent_app_number] => 15/319958
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 22561
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319958
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/319958 | Treatment of polybacterial infections | Jun 18, 2015 | Issued |
Array
(
[id] => 11627287
[patent_doc_number] => 20170137476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'Chimeric Vaccine Against Fungal Infections'
[patent_app_type] => utility
[patent_app_number] => 15/320225
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7343
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320225
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320225 | Chimeric vaccine against fungal infections | Jun 18, 2015 | Issued |
Array
(
[id] => 16970689
[patent_doc_number] => 11066652
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Vaccine for immunocompromised hosts
[patent_app_type] => utility
[patent_app_number] => 15/313327
[patent_app_country] => US
[patent_app_date] => 2015-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22752
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313327
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313327 | Vaccine for immunocompromised hosts | Jun 11, 2015 | Issued |
Array
(
[id] => 11541722
[patent_doc_number] => 20170095547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'MALARIAL ANTIGENS DERIVED FROM SUBTILISIN-LIKE PROTEASE 2 AND VACCINES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/314115
[patent_app_country] => US
[patent_app_date] => 2015-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10126
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314115
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314115 | MALARIAL ANTIGENS DERIVED FROM SUBTILISIN-LIKE PROTEASE 2 AND VACCINES AND METHODS OF USE | Jun 1, 2015 | Abandoned |
Array
(
[id] => 11820624
[patent_doc_number] => 20170209561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'VACCINE COMPOSITION AGAINST STREPTOCOCCUS SUIS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/314597
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6736
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314597
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314597 | VACCINE COMPOSITION AGAINST STREPTOCOCCUS SUIS INFECTION | May 28, 2015 | Abandoned |
Array
(
[id] => 11729629
[patent_doc_number] => 20170191073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'INCREASING LIPID PRODUCTION AND OPTIMIZING LIPID COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/313187
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20954
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313187
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313187 | Increasing lipid production and optimizing lipid composition | May 28, 2015 | Issued |
Array
(
[id] => 11756023
[patent_doc_number] => 20170202890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'NOVEL LACTIC ACID BACTERIUM AND COMPOSITION INCLUDING SAID LACTIC ACID BACTERIUM'
[patent_app_type] => utility
[patent_app_number] => 15/314829
[patent_app_country] => US
[patent_app_date] => 2015-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5712
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314829
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314829 | Lactic acid bacterium and composition including said lactic acid bacterium | May 27, 2015 | Issued |
Array
(
[id] => 11542631
[patent_doc_number] => 20170096457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/311667
[patent_app_country] => US
[patent_app_date] => 2015-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13900
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15311667
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/311667 | ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE | May 14, 2015 | Abandoned |
Array
(
[id] => 11742844
[patent_doc_number] => 20170196917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'AGENT FOR PREVENTION AND TREATMENT OF CHLAMYDIA INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/309551
[patent_app_country] => US
[patent_app_date] => 2015-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4476
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15309551
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/309551 | AGENT FOR PREVENTION AND TREATMENT OF CHLAMYDIA INFECTION | May 13, 2015 | Abandoned |
Array
(
[id] => 11668522
[patent_doc_number] => 20170157241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'COMPOSITIONS AND METHODS OF ENHANCING IMMUNOGENICITY OF POLYSACCHARIDE PROTEIN CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 15/310055
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51611
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310055
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310055 | Compositions and methods of enhancing immunogenicity of polysaccharide protein conjugates | May 7, 2015 | Issued |
Array
(
[id] => 15782505
[patent_doc_number] => 10624955
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
[patent_app_type] => utility
[patent_app_number] => 15/309177
[patent_app_country] => US
[patent_app_date] => 2015-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 40566
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15309177
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/309177 | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo | May 6, 2015 | Issued |
Array
(
[id] => 11491515
[patent_doc_number] => 20170065700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE'
[patent_app_type] => utility
[patent_app_number] => 15/308899
[patent_app_country] => US
[patent_app_date] => 2015-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12764
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308899
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308899 | VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE | May 4, 2015 | Abandoned |
Array
(
[id] => 11714898
[patent_doc_number] => 20170183397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'MULTI-SPECIFIC ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/308635
[patent_app_country] => US
[patent_app_date] => 2015-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30747
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308635
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308635 | MULTI-SPECIFIC ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES AND USES THEREOF | May 3, 2015 | Abandoned |